Currently out of the existing stock ratings of Yanan Zhu, 114 are a BUY (75%), 38 are a HOLD (25%).

Yanan Zhu

Work Performance Price Targets & Ratings Chart

Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 35.62% that have a potential upside of 34.03% achieved within 71 days.

Yanan Zhu’s has documented 298 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on PHVS, Pharvaris BV at 09-Sep-2026.

Wall Street Analyst Yanan Zhu

Analyst best performing recommendations are on RGLS (REGULUS THERAPEUTICS).
The best stock recommendation documented was for RGLS (REGULUS THERAPEUTICS) at 3/27/2025. The price target of $6 was fulfilled within 34 days with a profit of $4.5 (300%) receiving and performance score of 88.24.

Average potential price target upside

ARGX argenx NV ADR EDIT Editas Medicine RAPT RAPT Therapeutics AVRO AVROBIO BLUE Bluebird bio SGMO Sangamo Therapeutics AGLE Aeglea Bio Therapeutics AGTC Applied Genetic TSHA Taysha Gene Therapies BEAM Beam Therapeutics NTLA Intellia Therapeutics AFMD Affimed NV AUTL Autolus Therapeutics Ltd FATE Fate Therapeutics IOVA Iovance Biotherapeutics RNA Avidity Biosciences GRCL Gracell Biotechnologies TCRT Alaunos Therapeutics IONS Ionis Pharmaceuticals SYRE Spyre Therapeutics ARCT Arcturus Therapeutics Holdings CCXI ChemoCentryx MNTA Momenta Pharmaceuticals QURE Uniqure NV RGLS Regulus Therapeutics SRPT Sarepta Therapeutics VYGR Voyager Therapeutics ENGN enGene Holdings Common Stock MGX Metagenomi, Common Stock NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares BL Blackline CRSP Crispr Therapeutics AG CYTK Cytokinetics MORF Morphic PHVS Pharvaris BV

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Nov-2017

$1150

$190.51 (19.86%)

$1150

21 days ago
(08-Sep-2026)

33/36 (91.67%)

$142.93 (14.19%)

126

Buy Since 03-Jul-2025

$1250

$290.51 (30.28%)

$1230

29 days ago
(31-Aug-2026)

2/4 (50%)

$218.34 (21.16%)

192

Hold Since 06-Nov-2023

$1400

$440.51 (45.91%)

$910

1 months 3 days ago
(26-Aug-2026)

7/8 (87.5%)

$352.9 (33.70%)

218

Buy Since 14-Sep-2018

$1415

$455.51 (47.47%)

$1260

1 months 3 days ago
(26-Aug-2026)

21/28 (75%)

$367.9 (35.14%)

204

Buy Since 14-May-2020

$1200

$240.51 (25.07%)

$932

1 months 11 days ago
(18-Aug-2026)

20/21 (95.24%)

$207.01 (20.85%)

182

Show more analysts

Please expand the browser size to see the chart

Which stock is Yanan Zhu most bullish on?

Potential upside of $50.5 has been obtained for IONS (IONIS PHARMACEUTICALS)

Which stock is Yanan Zhu most reserved on?

Potential downside of $0.04 has been obtained for ENGN (ENGENE HOLDINGS COMMON STOCK)

What Year was the first public recommendation made by Yanan Zhu?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?